Trial site
St James's University Hospital, Leeds Teaching Hospitals NHS Trust
Leeds, LS9 7TF, United KingdomNot linked to an institution yet
The trials here
What the 10 trials at this site are about, from their registry records.
- Phase
- Phase 35 trials
- Phase 24 trials
- Status
- Active, not recruiting5 trials
- Recruiting4 trials
- Not yet recruiting1 trial
- Lead sponsor
- BioNTech SE5 trials
- Incyte Corporation3 trials
- University of Birmingham2 trials
Running trials
Recruiting
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
NCT07623200· Phase 3· Incyte Corporation· Source
Active, not recruiting
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT07214779· Phase 3· Incyte Corporation· Source
Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
NCT07173751· Phase 3· BioNTech SE· Source
Active, not recruiting
A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy
NCT06821542· Phase 3· Incyte Corporation· Source
Recruiting
Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment
NCT06841055· Phase 2· BioNTech SE· Source
Recruiting
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
NCT06712355· Phase 3· BioNTech SE· Source
Active, not recruiting
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
NCT06449222· Phase 2· BioNTech SE· Source
Active, not recruiting
Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy
NCT06449209· Phase 2· BioNTech SE· Source
Active, not recruiting
ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
NCT05629702· Phase 2· University of Birmingham· Source
Recruiting
Tessa Jowell BRAIN MATRIX - Platform Study
NCT04274283· University of Birmingham· Source
Contact: Ryan Mathew (principal investigator)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error